Influenza Virus Vaccine Production in disposable bioreactors

Discussion on preparedness for a possible influenza pandemic is still ongoing. Authorities and public interest have now accelerated the development of alternative production systems to the classical egg-based production. New disposable bioreactors have been evaluated in the upstream processing group using different analytical tools comparing the influenza virus production with two different mammalian cells. These bioreactors show a potential for fast and simple up-scaling of production capacities in case of a pandemic.